ORKA vs OSTX

Oruka Therapeutics, Inc. vs OS Therapies Incorporated — Valuation Comparison 2026

ORKA

Biotechnology
Oruka Therapeutics, Inc.
Quality
4.3
out of 10
Value Trap
12
SAFE
Price
$57.98
Last close
Models
10/13
Active
VS

OSTX

Biotechnology
OS Therapies Incorporated
Quality
3.1
out of 10
Value Trap
12
SAFE
Price
$1.98
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType ORKA Fair ValueORKA Upside OSTX Fair ValueOSTX Upside
Bayesian DCF Intrinsic $17.90 -69.1% $0.52 -74.0%
Earnings Power Value Intrinsic $31.09 -55.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $55.48 -4.3% $2.10 +5.9%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for ORKA vs OSTX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ORKA vs OSTX — Which Stock Is More Undervalued?

ORKA scores higher with a 4.3/10 quality rating vs OSTX's 3.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Oruka Therapeutics, Inc. (ORKA) and OS Therapies Incorporated (OSTX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ORKA currently trades at $57.98 with a QOC of 4.3/10, while OSTX trades at $1.98 with a QOC of 3.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).